Medifair Cream

Medifair Cream is a topical application used to treat melasma, a skin condition characterised by dark, discoloured patches. It provides a skin-lightening effect and reduces symptoms of redness, itching, swelling, hyperpigmentation and discolouration.

This prescription medicine contains three ingredients: hydroquinone, a skin-lightening agent used for hyperpigmentation; mometasone, a corticosteroid that treats swelling and redness; and tretinoin, a retinoic acid made from vitamin A, which promotes the renewal of skin cells.

Medifair Cream is meant for external use only. Check the labels and instructions before applying. Do not apply on cuts, wounds and burnt skin. Avoid contact with eyes, nose, ears or mouth. Follow your doctor’s instructions on the duration and dosage of this topical application.

The usage of Medifair Cream does not usually cause severe side effects. You may experience redness, dryness and swelling around the applied area, but it will resolve once the skin gets used to the medicine. Contact your doctor if you experience rare but serious symptoms like severe skin rash or bluish-black pigmentation.

This medicine is considered safe for most people. However, speak with your doctor if you have the following conditions: eczema (a set of skin conditions that cause dry and irritated skin), asthma, diabetes, Cushing's syndrome (the overproduction of hormone cortisol), actinic keratoses (rough, scaly patches that develop from prolonged sun exposure), skin cancer, or other skin conditions.

Medifair Cream is a topical application used to primarily treat melasma, a skin condition characterised by dark, discoloured patches. This condition usually affects women, especially during pregnancy. People with melasma tend to have brownish-coloured patches, which typically appear on the cheeks, forehead, chin and nose. This medication treats this skin condition by reducing redness and discolouration. It also promotes the shedding of old skin cells and the growth of new healthy ones.

This prescription medicine contains three ingredients: hydroquinone, a skin lightening (bleach) agent used for hyperpigmentation; mometasone, a corticosteroid that treats swelling and redness by its immunosuppressive effect; and tretinoin, a retinoic acid (derivative of vitamin A) which promotes the renewal of skin cells.

Your doctor will prescribe you Medifair Cream for a specific duration after assessing the extent of pigmentation/discolouration. Be sure to apply the cream evenly on a clean surface of the skin for the best results. After the discolouration fades, you should continue the application to prevent the patches from reappearing.

Medifair Cream contains hydroquinone, mometasone and tretinoin. This combination works by lightening the skin, getting rid of hyperpigmentation, reducing excessive redness and promoting the renewal of new healthy skin cells.

Hydroquinone (benzene-1,4-diol or quinol) is an aromatic organic chemical derived from benzene. It is a skin-lightening agent used in the treatment of different forms of hyperpigmentation. This medicine works by decreasing the number of melanocytes (the cells which produce melanin that gives the skin its colour). Hydroquinone is an effective treatment for hyperpigmentation because this condition is caused by an increase in melanocyte production.

Mometasone is a hormone medicine (corticosteroid) used to treat skin conditions such as itching, swelling and irritation. It works by preventing or blocking the skin cells from producing chemicals that cause inflammation. These chemicals can be triggered due to a variety of different factors.

Tretinoin is a man-made vitamin A which is used to treat acne and discolouration. It also promotes the regeneration of new healthy skin. Tretinoin binds to the two nuclear receptor types within keratinocytes, a type of skin cell. This binding results in decreased cohesiveness of keratinocytes and reduced microcomedone formation.

Medifair Cream contains three ingredients: hydroquinone, mometasone and tretinoin. The third ingredient, tretinoin, also known as all-trans retinoic acid is a synthetic form of vitamin A. It can be used in two ways.

When it is applied to the skin in the form of an ointment or a cream (as a topical application), it can treat acne and discolouration and promotes the regeneration of new healthy skin. Tretinoin binds to two nuclear receptor types within keratinocytes, a type of skin cell. This binding results in decreased cohesiveness of keratinocytes and reduced microcomedone formation.

When taken orally, tretinoin can be used to treat leukaemia, specifically to induce remission of acute promyelocytic leukaemia. It is a kind of blood cancer characterised by a marked increase in promyelocytes, a type of immature white blood cells. The mechanism of action of this drug in cancer treatment is unknown as of now. Tests, however, conclusively show that tretinoin prevents the cancer cells from proliferating/multiplying.

• Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy
• Color Atlas and Synopsis of Clinical Dermatology